We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 81-100 of 6,570 results
  1. The Short- and Long-Term Surgical Results of Consecutive Hepatopancreaticoduodenectomy for Wide-Spread Biliary Malignancy

    Background

    Cancer-free resection (R0) is one of the most important factors for the long-term survival of biliary carcinoma. For some patients with...

    Yasunori Yoshimi, Takehiro Noji, ... Satoshi Hirano in Annals of Surgical Oncology
    Article 29 October 2023
  2. Preoperative plasma D-Dimer level is correlated with peritoneal cancer index of patients with pseudomyxoma peritonei

    Purpose

    Accurate assessment of preoperative tumor burden contribute to formulate a scientific surgical plan for patients with pseudomyxoma peritonei...

    **g Feng, Changhai Qi, ... Mingjian Bai in BMC Surgery
    Article Open access 31 October 2022
  3. Cytoreductive Surgery With or Without HIPEC in the Management of Peritoneal Dissemination from Rare Histological Subtypes of Ovarian Cancer — a Retrospective Study by INDEPSO

    The aim of this study was to evaluate the potential role of optimal cytoreductive surgery with or without HIPEC in the management of peritoneal...

    Snita Sinukumar, Dileep Damodaran, ... Aditi Bhatt in Indian Journal of Surgical Oncology
    Article 07 September 2022
  4. The Role of Hyperthermic Intraperitoneal Chemotherapy for Non-colorectal Peritoneal Surface Malignancies

    Background

    Peritoneal carcinomatosis, from a variety of gastrointestinal and gynecological malignancies, has been historically challenging to treat...

    Mackenzie C. Morris, Jordan M. Cloyd, ... Sameer H. Patel in Journal of Gastrointestinal Surgery
    Article 17 August 2020
  5. High visceral fat-to-muscle ratio is an independent factor that predicts worse overall survival in patients with primary epithelial ovarian, fallopian tube, and peritoneal cancer

    Background

    The intra-abdominal cavity, surrounded by adipocytes, is the main metastatic site of epithelial ovarian, fallopian tube, and peritoneal...

    Sooji Ham, ** Hwa Choi, ... Eun-Ju Lee in Journal of Ovarian Research
    Article Open access 21 January 2023
  6. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal peritoneal metastases: analysis of short- and long-term outcomes

    Background

    Peritoneal metastases carry the worst prognosis among all sites of colorectal cancer (CRC) metastases. In recent years, the advent of...

    Fausto Rosa, Federica Galiandro, ... Sergio Alfieri in Langenbeck's Archives of Surgery
    Article Open access 18 October 2021
  7. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Gastric Metastases

    The Chicago Consensus Working Group provides multidisciplinary recommendations for the management of gastric cancer specifically as it relates to the...

    Francisco J. Izquierdo, Darryl Schuitevoerder, ... Kiran Turaga in Annals of Surgical Oncology
    Article 13 April 2020
  8. CT imaging of peritoneal carcinomatosis with surgical correlation: a pictorial review

    Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy has revolutionized the survival and the quality of life in...

    Panagiota Berta Panagiotopoulou, Nikos Courcoutsakis, ... Panos Prassopoulos in Insights into Imaging
    Article Open access 12 November 2021
  9. Feasibility and Safety of Taxane-PIPAC in Patients with Peritoneal Malignancies—a Retrospective Bi-institutional Study

    Taxanes have a favorable pharmacokinetic profile for intraperitoneal application. We report our initial experience with taxane-PIPAC (pressurized...

    Sanket Mehta, Praveen Kammar, ... Aditi Bhatt in Indian Journal of Surgical Oncology
    Article 07 September 2022
  10. Ten-year single-center experience with treatment of primary diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)

    Purpose

    This single-center study evaluated cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for diffuse...

    Miklos Acs, Michael Gerken, ... Pompiliu Piso in Langenbeck's Archives of Surgery
    Article 23 June 2022
  11. Cytoreductive Surgery with HIPEC is a Safe and Effective Palliative Option in Chemorefractory Symptomatic Peritoneal Metastasis

    Introduction

    The safety and efficacy of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal metastasis in...

    Chunmeng Zhang, Asish Patel, ... Jason M. Foster in Annals of Surgical Oncology
    Article 24 February 2022
  12. Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion for Pancreatic Cancer with Low-Volume Peritoneal Metastasis: Results from a Prospective Pilot Study

    Introduction

    Resection of oligometastatic pancreatic ductal adenocarcinoma (PDAC) has historically been ineffective, however modern systemic...

    Travis E. Grotz, Jennifer A. Yonkus, ... Mark J. Truty in Annals of Surgical Oncology
    Article 16 August 2022
  13. Randomized phase III trial of intravenous and intraperitoneal paclitaxel with S-1 versus gemcitabine plus nab-paclitaxel for pancreatic ductal adenocarcinoma with peritoneal metastasis (SP study)

    The prognosis of pancreatic ductal carcinoma (PDAC) with peritoneal metastasis remains dismal. Systemic chemotherapy alone may not be effective, and...

    Tomohisa Yamamoto, Tsutomu Fujii, ... Sohei Satoi in Trials
    Article Open access 05 February 2022
  14. Primary and secondary tumors of the peritoneum: key imaging features and differential diagnosis with surgical and pathological correlation

    Peritoneal malignancies represent a diagnostic challenge for abdominal radiologists, oncologists, surgeons and pathologists in multidisciplinary...

    Javier Miguez González, Francesc Calaf Forn, ... Juan Ramón Ayuso Colella in Insights into Imaging
    Article Open access 03 July 2023
  15. Survival Outcomes for Malignant Peritoneal Mesothelioma at Academic Versus Community Hospitals

    Background

    Malignant peritoneal mesothelioma is a rare disease with poor outcomes. Cytoreductive surgery with hyperthermic intraperitoneal...

    Vanessa M. Welten, Adam C. Fields, ... Nelya Melnitchouk in Journal of Gastrointestinal Surgery
    Article 21 July 2021
  16. Lymph Node Metastases from Visceral Peritoneal Colorectal Metastases are Associated with Systemic Recurrence

    Background

    Visceral peritoneal colorectal metastases (VPCMs) may further metastasize to lymph nodes that drain those organs. The rate of lymph node...

    Eran Nizri, Yaniv Berger, ... Ravit Geva in Annals of Surgical Oncology
    Article 07 October 2021
  17. The Chicago Consensus on Peritoneal Surface Malignancies: Palliative Care Considerations

    The Chicago Consensus Working Group provides multidisciplinary recommendations for palliative care specifically related to peritoneal surface...

    Alejandro Plana, Francisco J. Izquierdo, ... Kiran Turaga in Annals of Surgical Oncology
    Article 13 April 2020
  18. Benign multicystic peritoneal mesothelioma occurring in bilateral inguinal canals metachronously: a case report

    Background

    Benign multicystic peritoneal mesothelioma (BMPM) is a benign tumor that usually occurs in middle-aged females. Although several published...

    Hiroyuki Oshikiri, Yohei Ozawa, ... Go Miyata in Surgical Case Reports
    Article Open access 16 March 2022
Did you find what you were looking for? Share feedback.